News in 2018

  • Human papilloma virus: 10 years of vaccination 21 December 2018 Prof Adam Finn presented at an anniversary event in Portugal celebrating 10 years of the integration of the human papilloma virus (HPV) vaccine into the country’s National Vaccination Program.
  • Winners of the prizes for the Best Doctoral Research Theses 2017/18 5 December 2018 Six Bristol postgraduates have been awarded £500 prizes for the exceptional quality of their research degree theses.
  • Women who are 'larks' have a lower risk of developing breast cancer 6 November 2018 Women who are 'larks', functioning better at the beginning of the day than the end of the day, have a lower of risk breast cancer, according to new research led by the University of Bristol presented at the 2018 NCRI Cancer Conference today [Tuesday 6 November].
  • Bristol to join forces with one of the world’s most prestigious research societies 6 November 2018 The University of Bristol partners with the Max Planck Society in Germany to establish an innovative new Max Planck Centre for Minimal Biology in Bristol. The Centre will pursue game-changing research in the emerging field of minimal biology to address some of the most complex challenges in fundamental science. This could lead to transformative applications in biotechnology and medicine.
  • Fluorescent marker can help guide surgeons to remove dangerous brain tumour cells more accurately 5 November 2018 A chemical that highlights tumour cells has been used by surgeons to help spot and safely remove brain cancer in a trial presented by a University of Bristol academic at the 2018 NCRI Cancer Conference.
  • Inflammation as a predictive tool for cancer 19 October 2018 Head and neck squamous cell carcinoma (HNSCC) is often associated with chronic systemic inflammation (SI). A team from the Integrative Cancer Epidemiology Programme (ICEP) assessed if DNA methylation-derived SI (mdSI) indices: Neutrophil-toLymphocyte ratio (mdNLR) and Lymphocyte-to-Monocyte ratio (mdLMR) are associated with the presence of HNSCC and overall survival (OS).
  • Serum calcium’s role in prostate cancer 11 October 2018 Prostate cancer is the most frequently diagnosed cancer among men and is a common cause of male cancer death. Global variation in mortality and findings from migration studies provide support for a role of modifiable risk in prostate carcinogenesis.
  • Scientists create synthetic prototissue capable of synchronised beating 10 October 2018 A tissue-like material capable of synchronised beating when heated and cooled has been developed by a team of University of Bristol chemists.
  • Early detection of Cancer Conference 9 October 2018 Becky Richmond attended “The Early Detection of Cancer Conference” at the OHSU Knight Cancer Institute in Portland, Oregon on 2-4 October 2018.
  • Wellcome Board of Governors visit Bristol to hear about innovative research 26 September 2018 Dr Jeremy Farrar, Director of Wellcome, one of the UK’s largest research funders, visited Bristol this week [25 Sept] to meet senior staff and researchers and understand how Wellcome funding is used, explore issues of joint concern in the UK science base, and discuss future opportunities with the University.
  • University of Bristol joins UK BioIndustry Association 26 September 2018 The University of Bristol staff can now benefit from the organisational membership of the UK BioIndustry Association through the support provided by the Elizabeth Blackwell Institute.
  • Biomarker tool for cancer immunotherapy 21 September 2018 New immunotherapies which help the immune system to recognise and destroy cancer cells are promising, but some patients don’t respond to the new treatments. With the help of an Elizabeth Blackwell Institute Clinical Primer Scheme award, Dr Emily Milodowski has been developing a new tool as a step towards being able to identify people who can be helped by these new therapies.
  • Treatment for diffuse intrinsic pontine glioma 20 September 2018 Diffuse intrinsic pontine glioma (DIPG) is a lethal, high-grade, paediatric glioma that accounts for up to 85% of all brainstem gliomas and 100-150 new cases are recorded each year in the USA. DIPG is difficult to treat due to the heterogeneity generated from the various mutations associated with the disease, as well as its sensitive location in the brainstem. Chemotherapies have proved ineffective and new treatments are urgently required.
  • New network launched to enhance the rigour and reliability of UK scientific research 12 September 2018 A new Reproducibility Network that aims to improve the rigour and reliability of UK-led scientific research will launch at the University of Bristol this week [Wednesday 12 September]. The Network aims to reinforce the leading position of UK science by co-ordinating shared training and best practice across research-intensive universities.
  • Disappearing into thin air: harnessing oxygen drop could eliminate cancers without harming healthy tissue 4 September 2018 A major advance towards targeting cancer without harming healthy tissue has been discovered by University of Bristol researchers. The team has found a way to exploit hypoxia (reduced oxygen levels) — a condition which occurs during the development of many common cancers and drives their progression and spread. The findings, which have implications for targeted oncology, were published on 24 August 2018 in the journal EMBO Molecular Medicine.
  • Anti-cancer drug offers potential alternative to transplant for patients with liver failure, study finds 16 August 2018 Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows. The study by scientists at University of Edinburgh MRC Centre for Regenerative Medicine, the Cancer Research UK Beatson Institute in Glasgow, and the University of Bristol, is published in Science Translational Medicine.
  • Bristol launches the new Faculty of Life Sciences 1 August 2018 The start of August sees the creation of a brand-new faculty at the University of Bristol – the Faculty of Life Sciences.
  • Science Surgery: ‘Will cancer ever be eradicated completely?’ 26 July 2018 Part of Cancer Research UK’s Science Surgery series which answers cancer science questions submitted by the public.
  • Bristol thinking globally for health 18 July 2018 Rachael Gooberman-Hill, Director of Elizabeth Blackwell Institute for Health Research, University of Bristol, describes the Institute's innovative approach to global health challenges. This blog is part of the Bristol Firsts series, celebrating Bristol-based innovations in the NHS’s 70th year.
  • CRUK awards Bristol researcher £1.4 million to investigate cancer growth containment 6 July 2018 University of Bristol researcher, Professor Eugenia Piddini from the School of Cellular and Molecular Medicine, has been awarded a Programme Foundation Award worth £1.4 million by Cancer Research UK (CRUK) to lead research into how the natural properties of normal non-cancer cells can be harnessed to contain cancer growth.
  • Collaborating outside of the Life Sciences 6 July 2018 In a recent article for Physics World, David Scott, Cancer Research UK's Director of Discovery Research and Research Communications, explores the importance of collaboration between cancer researchers and physicists and how CRUK are facilitating these important partnerships.
  • Cancer in the UK: State of the Nation Report 6 July 2018 Cancer Research UK have released their latest report summarising the current state of cancer in the UK – spanning prevention, diagnosis, treatment and survival – highlighting the progress being made as well as the challenges the UK still faces.
  • Weeding out childhood leukaemia – fighting cancer with nature 31 May 2018 New research, led by cancer biologists from the University of Bristol, has shown that bone marrow cells can protect cancer cells from a plant derived anti-cancer agent called Parthenolide.
  • New evidence on link between obesity and smoking behaviour from genetic data: obese people at higher risk of smoking 25 May 2018 A study by the International Agency for Research on Cancer (IARC) provides new evidence that increased weight and obesity may result in increased smoking. The Cancer Research UK (CRUK)-funded study, involving University of Bristol researchers and published today in the British Medical Journal (BMJ), found that increased body mass index (BMI), body fat percentage, and waist circumference were associated both with a higher risk of being a smoker and with greater smoking intensity, measured by the number of cigarettes smoked per day. These results were consistent in both men and women.
  • Can a home WiFi router act as a medical sensing device? 10 May 2018 New research that could transform the future of healthcare will investigate whether it is possible to reuse WiFi radio waves as a medical radar system. The research, led by the University of Bristol, is part of a new £1.5 million grant awarded by the Engineering and Physical Sciences Research Council (EPSRC), Toshiba and Decawave to the OPERA project, a consortium including the universities of Bristol and Oxford; University College London and Coventry University.
  • EBI funded project awarded further funds to continue prehabilitation work for cancer patients 9 May 2018 Thanks to initial funding from University of Bristol’s Elizabeth Blackwell Institute we are now close to seeing some real impact from a prehabilitation intervention for cancer patients undergoing major surgery. The project, which aims to identify interventions that improve post-operative recovery, has been awarded further funding to take forward this important research.
  • New CEO of Cancer Research UK 4 May 2018 Michelle Mitchell OBE has been appointed as CEO of Cancer Research UK. She will replace Sir Harpal Kumar who is due to stand down in the summer.
  • Screening and treatment for prostate cancer: two trials address the controversies 19 April 2018 Jenny Donovan, Professor of Social Medicine, University of Bristol and Director of the NIHR Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) on the recent findings from two large prostate cancer trials that she has led.
  • Collaborative research to improve health and care 18 April 2018 Scientists are collaborating with NHS and public health staff to ensure that research evidence is used effectively to improve public health and patient outcomes. Professor Jenny Donovan, NIHR CLAHRC West Director, and Lara Edwards, NIHR CLAHRC West Manager, explain why collaboration is so important and offer some examples of the benefits it brings.
  • Outpatient treatment for cancer condition offers effective new approach for patients 5 April 2018 A novel approach to treating fluid build-up around the lungs of cancer patients could deliver a more effective home-based treatment for thousands of people who might be approaching the end of their lives, according to a new study led by the University of Bristol and North Bristol NHS Trust.
  • Bristol scientists behind the largest trial ever to investigate prostate cancer screening 12 March 2018 Inviting men with no symptoms to a one-off PSA* test for prostate cancer does not save lives according to results from the largest ever trial conducted by Cancer Research UK-funded scientists based at the University of Bristol.
  • Bristol Bladder trial 21 February 2018 A Phase II Trial of combination Cabazitaxel and Cisplatin Chemotherapy in the Neoadjuvant Treatment of Transitional Cell Carcinoma of the Urinary Bladder.
  • A multi-modal approach to prehabilitation in patients undergoing major surgery for cancer 14 February 2018 Dr Maria Pufulete (Research Fellow, Clinical Trials and Evaluation Unit at the UoB) has been awarded £1,854,558 from the NIHR Technology Assessment Programme
  • Lung cancer drug resistance explained by computer simulations 12 February 2018 Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer.
  • MP Thangam Debbonaire visits Bristol to meet scientists behind cutting edge cancer research 2 February 2018 Ahead of World Cancer Day on Sunday, Bristol West MP, Thangam Debbonaire, visited the University of Bristol’s School of Cellular and Molecular Medicine today, 2 February, to meet researchers and explore the laboratories where cutting edge cancer research takes place.
  • Poster Presentation on TeMMPo in Texas 1 February 2018 The American Association for Cancer Research hosted the Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes conference 27-30 January 2018 in Austin, Texas.
  • Immediate breast reconstruction after mastectomy does not delay start of chemotherapy or radiotherapy – but may increase risk of complications and readmission 25 January 2018 Having immediate reconstruction following a mastectomy does not delay the start of a patient’s adjuvant breast cancer therapy but may increase the likelihood of complications requiring hospital readmission in the first six weeks after surgery, according to new research led by researchers at the University of Bristol and the Royal Liverpool University Hospital presented at the UK Interdisciplinary Breast Cancer Symposium (UKIBCS) in Manchester – hosted by leading charity Breast Cancer Now.
  • Bursaries for ICEP 10 January 2018 Claire Prince and Mark Gormley have both recently been awarded bursaries for their work with the Integrative Cancer Epidemiology Programme (ICEP).
  • Bristol appoints Professor Tavaré to lead new Faculty of Life Sciences 9 January 2018 Professor Jeremy Tavaré will take up the role of Dean when the University of Bristol’s new Faculty of Life Sciences is officially launched on 1 August this year.
Edit this page